77 related articles for article (PubMed ID: 10855565)
1. Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation.
Karasen RM; Sutbeyaz Y; Aktan B; Ozdemir H; Gundogdu C
Ann Otol Rhinol Laryngol; 2000 Jun; 109(6):549-53. PubMed ID: 10855565
[TBL] [Abstract][Full Text] [Related]
2. Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the rabbit model of sinusitis.
Karasen RM; Uslu C; Gundogdu C; Taysi S; Akcay F
Ann Otol Rhinol Laryngol; 2004 Jun; 113(6):477-82. PubMed ID: 15224833
[TBL] [Abstract][Full Text] [Related]
3. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation.
Sutbeyaz Y; Yakan B; Ozdemir H; Karasen M; Doner F; Kufrevioglu I
Ann Otol Rhinol Laryngol; 1996 Jun; 105(6):476-80. PubMed ID: 8638901
[TBL] [Abstract][Full Text] [Related]
4. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
[TBL] [Abstract][Full Text] [Related]
5. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
Diven WF; Burckart GJ; Alper CM; Jaffe R; Evans RW; Doyle WJ
Ann Otol Rhinol Laryngol; 1998 Mar; 107(3):199-206. PubMed ID: 9525240
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
9. Effects of the platelet-activating factor receptor antagonist WEB 2086 on whole blood coagulation and fibrinolysis in a thromboelastography assay.
Dambisya YM; Lee TL; Hussaini IM
Blood Coagul Fibrinolysis; 1995 Dec; 6(8):733-7. PubMed ID: 8825223
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
Borman RA; Jewell R; Hillier K
Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
[TBL] [Abstract][Full Text] [Related]
11. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
Miguélez R; Palacios I; Navarro F; Gutierrez S; Sanchez-Pernaute O; Egido J; González E; Herrero-Beaumont G
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):35-49. PubMed ID: 8821809
[TBL] [Abstract][Full Text] [Related]
13. Hetrazepine PAF antagonists.
Ikegami K; Meade CJ; Heuer HO; Birke F
J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) receptor antagonism by WEB 2170 improves the survival of ischaemic skeletal muscle.
Lepore DA; Knight KR; Stewart AG; Riccio M; Morrison WA
Ann Acad Med Singap; 1995 Jul; 24(4 Suppl):63-7. PubMed ID: 8572529
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Giembycz MA; Kroegel C; Barnes PJ
J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
[TBL] [Abstract][Full Text] [Related]
18. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
